From Craft to Commodity: The Evolution of AI in Pharma and Beyond

Citation:

Hannah Mayer, Jin H. Paik, Timothy DeStefano, and Jenny Hoffman. Working Paper. “From Craft to Commodity: The Evolution of AI in Pharma and Beyond”.

Abstract:

While there are dispersed resources to learn more about artificial intelligence, there remains a need to cultivate a community of practitioners for cyclical exposure and knowledge sharing of best practices in the enterprise. That is why Laboratory for Innovation Science at Harvard launched the AI in the Enterprise series, which exposes managers and executives to interesting applications of AI and the decisions behind developing such tools. 

Moderated by HBS Professor and co-author of Competing in the Age of AI, Karim R. Lakhani, the August virtual session featured Reza Olfati-Saber, an experienced academic researcher currently managing teams of data scientists and life scientists across the globe for Sanofi. Together, they discussed the evolution of AI in life science experimentation and how it may become the determining factor for R&D success in pharma and other industries.

Last updated on 10/29/2020